Table 1: Patient
Characteristics.
|
Characteristic |
Total (n=71) |
|
Age,
median (IQR) |
71
(66-85) |
|
Sex |
|
|
Male
|
53
(75%) |
|
Female
|
18
(25%) |
|
Performance Status (ECOG) |
|
|
0-
1 |
43
(61%) |
|
2-3
|
28
(39%) |
|
Primary tumor |
|
|
Lung
|
16
(23%) |
|
Colon |
9
(13%) |
|
Prostate
|
5
(7%) |
|
Urothelial
|
4
(6%) |
|
Liver
|
4
(6%) |
|
Gynaecologic
|
4
(6%) |
|
Breast
|
2
(3%) |
|
Other
Gastrointestinal |
17
(24%) |
|
Other
Genitourinary |
3
(4%) |
|
Others
|
7
(10%) |
|
Metastasis |
|
|
Yes
|
53
(75%) |
|
No
|
18
(25%) |
|
Ongoing treatment |
|
|
Chemotherapy
|
22
(31%) |
|
Chemotherapy
+ Immunotherapy |
7
(10%) |
|
Immunotherapy
only |
9
(13%) |
|
Target
therapy |
13
(18%) |
|
Supportive
care |
8
(11%) |
|
Others
or none |
12
(17%) |